Related Experiment Video
Updated: May 5, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Rift Valley Fever Virus: An update on current status and future prospects
Arwa Ahmed Zehairy1, Sayed Sartaj Sohrab2, Awatif Abid Al-Judaibi3
1Special Infectious Agents Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah 21589, Saudi Arabia; University of Jeddah, Faculty of Science, Department of Biological sciences, Jeddah, Saudi Arabia.
None:
Rift Valley fever is a mosquito-borne disease caused by the Rift Valley Fever Virus (RVFV) belonging to the genus Phlebovirus. This virus causes febrile or hemorrhagic illness in humans and ruminants, such as abortion, and death; especially in young sheep, cattle, and goats resulting in devastating epidemics in Africa and the Arabian Peninsula. The WHO has included this virus in Bluepoint's list of eight pathogens. This virus is a crucial health concern in the Kingdom of Saudi Arabia (KSA), as the Kingdom is regularly exposed to this virus from the original source of East African countries. A complete understanding of viral pathogenesis, epidemiology, antiviral therapeutics, and human vaccines is still lacking. This review aims to provide an update on the status, pathogenesis, prevalence, challenges, and future prospects of RVFV in the KSA. The information provided will aid in the design and development of disease management strategies and novel prophylactic and therapeutic measures to control the infection and disease progression of RVFV in both humans and animals.
Related Concept Videos
Infectious Diseases and Their Occurrence
Arboviral Encephalitis

